Thad Cochran bought VGRAX (VGRAX)
Thad Cochran (R-MS), a U.S. Senator, has disclosed 1 trade in VGRAX (VGRAX) since 2014, a single purchase, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Thad Cochran bought $1,001 - $15,000 of VGRAX (VGRAX) on December 15, 2014. Since that trade, VGRAX is up +0.00% against the S&P 500 up +343.95%, an outperformance of -343.95%.
Data updated
Thad Cochran's VGRAX trades vs the price
VGRAX is up +0.00% since Thad Cochran bought on December 15, 2014, versus +343.95% for the S&P 500.
Performance since this trade
All Thad Cochran VGRAX trades
Thad Cochran & VGRAX trading FAQ
Is it legal for Thad Cochran to trade VGRAX (VGRAX) stock?
Yes. Members of Congress are allowed to trade individual stocks, including VGRAX (VGRAX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Thad Cochran buy VGRAX?
Thad Cochran disclosed a purchase of $1,001 - $15,000 of VGRAX (VGRAX) on December 15, 2014, according to public STOCK Act filings.
How has VGRAX performed since Thad Cochran's trade?
Since Thad Cochran bought VGRAX on December 15, 2014, the stock is up +0.00%, versus +343.95% for the S&P 500 over the same period, an outperformance of -343.95%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional VGRAX trades?
Quantellect tracks every disclosed congressional trade in VGRAX (VGRAX) on the VGRAX congressional trading page, which aggregates filings across all members of Congress.
Thad Cochran's VGRAX tradesAll congressional filings for VGRAXThad Cochran's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.